Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..."
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
"... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... prevention of cardiovascular diseases in patients with a history of myocardial infarction in ambulatory ..."
 
Vol 6, No 1 (2010) SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT Abstract  similar documents
N. A. Jaiani
"... Рассматриваются обоснования и преимущества применения ингибитора АПФ лизиноприла в практической ..."
 
Vol 1, No 3 (2005) COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS Abstract  similar documents
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin
"... drugs of ACE inhibitor and diuretic, “Noliprel forte” (NF) and “Capozide” (CA), in hypertensive high ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... , treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular ..."
 
Vol 5, No 1 (2009) ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL Abstract  similar documents
V. I. Podzolkov, K. K. Osadchy
"... Approaches to the choice of antihypertensive pharmacotherapy are discussed. Evidence base of ACE ..."
 
Vol 10, No 5 (2014) CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES Abstract  similar documents
N. A. Dzhaiani
"... Rationale and benefits of the use of the ACE inhibitor lisinopril in the clinical practice ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... enzyme (ACE) inhibitors in clinical practice were represented. The traditional usage of emACE/em inhibitors ..."
 
Vol 4, No 2 (2008) ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION Abstract  similar documents
M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva
"... Aim. To study effects of emACE/em inhibitor perindopril on markers of endothelial dysfunction ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... prescription frequency of drugs with proven effects on the emcardiovascular/em risk in patients with stable IHD ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... prevention of emcardiovascular/em diseases in patients with stable angina on the level of out-patient specialized ..."
 
Vol 5, No 3 (2009) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. N. Tereshchenko, N. A. Dzhaiani
"... The role of emACE/em inhibitors in modern pharmacotherapy of patients with chronic heart failure (CHF ..."
 
Vol 4, No 3 (2008) COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva
 
Vol 4, No 1 (2008) EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL” Abstract  similar documents
статья Редакционная
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
"... New possibilities of emACE/em inhibitors application on the base of international trails review ..."
 
Vol 3, No 2 (2007) RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION Abstract  similar documents
M. M. Batyushin, I. V. Derevyankina, M. Z. Gasanov, O. V. Akopova, K. I. Babiyan, Y. N. Boychenko, N. V. Vasilchenko, T. A. Gabysyan, S. Ch. Gayboryan, I. S. Golovatenko, N. M. Demkova, D. O. Dmitriev, E. V. Kirtava, O. L. Kotyankova, G. V. Ludanova, S. A. Lyashenko, A. E. Malichina, O. I. Poroshenko, A. V. Svechnikova, I. Y. Sidorov, E. V. Solyannikova, I. D. Tascheyan, E. A. Heygetyan, S. E. Evruyan
"... converting enzyme (emACE/em) inhibitor, thiazid diuretic (indapamide) and dihydropyridine calcium antagonist ..."
 
Vol 6, No 1 (2010) COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION Abstract  similar documents
S. A. Boitsov, R. M. Linchak
"... attention is paid to usage of emACE/em inhibitor and calcium antagonist combination. ..."
 
Vol 5, No 3 (2009) FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY Abstract  similar documents
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
 
Vol 1, No 1 (2005) ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES Abstract  similar documents
S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin
"... antihypertensive therapy based on emACE/em-inhibitor spirapril, the second one (control group) continued their usual ..."
 
Vol 2, No 4 (2006) POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN Abstract  similar documents
I. V. Logacheva, E. N. Shustova, E. V. Kulinich
"... (emACE/em inhibitor and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..."
 
Vol 5, No 2 (2009) CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL Abstract  similar documents
D. A. Napalkov, E. N. Golovenko
"... There is grate interest to emACE/em inhibitors which have cardioprotective and neproprotective effects ..."
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
 
Vol 9, No 2 (2013) FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE Abstract  similar documents
O. D. Ostroumova, I. I. Kopchenov
"... converting enzyme (emACE/em) inhibitor and dihydropyridine calcium antagonist are considered. Data on the efficacy ..."
 
Vol 4, No 1 (2008) COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky
 
Vol 9, No 1 (2013) MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina, B. B. Gegenava
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... with different emcardiovascular/em risk (according to arterial hypertension (HT) risk stratification) in real clinical ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (emACE/em) inhibitors keep important ..."
 
Vol 6, No 5 (2010) FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. O. Shevchenko, O. P. Shevchenko
"... and hydrochlorothiazide are discussed. Reasonability of emACE/em inhibitor and thiazide diuretic combination is supported due ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
"... ишемического инсульта. emОбсуждают/em результаты как классических исследований статинов при профилактике ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... to recommended therapy on the risk of emcardiovascular/em events during a year after hospital admission ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... Aim. To evaluate the availability and affordability of medicines used to treat of emcardiovascular/em ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... The main trails proven angiotensin converting enzyme (emACE/em) inhibitor effects on the life prognosis ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... Aim. To study a pattern of concomitant emcardiovascular/em diseases (CVDs) and to estimate ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... into the outpatient REgistry of emCardioVAScular/em diseAses (RECVASA). 530 of 3690 (14.4%) patients had the diagnosis ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... and the main indications are discussed. ASA use for primary emcardiovascular/em diseases prevention and its possible ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... The results of the main large controlled trials that had proven effect of emACE/em inhibitors (ACEi ..."
 
Vol 9, No 2 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... of emcardiovascular/em complications (antiplatelets, β-blockers, emACE/em inhibitors, statins) were not often prescribed ..."
 
Vol 10, No 4 (2014) QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER Abstract  similar documents
A. V. Zagrebelnyy, S. Yu. Martsevich, M. M. Loukianov, E. A. Pravkina, A. N. Vorobyev, S. S. Yakushin, S. A. Boytsov
"... received emACE/em inhibitors, 38.5% – diuretics, 32.5% – BBs. BBs were prescribed to the third part of patients ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... Aim. To estimate risk factors and comorbidity structure, emcardiovascular/em diseases outcomes ..."
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... The problem of varenicline use in patients with emcardiovascular/em diseases is discussed. Results ..."
 
Vol 7, No 5 (2011) СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Dzhaiani
"... situation with arterial hypertension. emACE/em inhibitors have a special place among the antihypertensive drugs ..."
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Data of studies devoted to application of angiotensin converting enzyme (emACE/em) inhibitors in acute ..."
 
Vol 8, No 1 (2012) PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE Abstract  similar documents
M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova
"... are an independent risk factor for emcardiovascular/em disease. The possibilities of GMD prevention and early treatment ..."
 
Vol 9, No 5 (2013) LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY Abstract  similar documents
O. I. Afanasieva, S. N. Pokrovsky
"... emОбсуждают/em использование антисмысловых олигонуклеотидов (АСО) для разработки препаратов для ..."
 
Vol 10, No 1 (2014) TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS Abstract  similar documents
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta
"... for the combination of an emACE/em inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of emcardiovascular/em drugs, such as statins, beta-blockers, emACE/em inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... Background. Effects of statins on emcardiovascular/em end points are well-known. To study the impact ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
 
Vol 14, No 5 (2018) Associations of Cardiovascular Risk Factors and Genetic Markers with Development of Arterial Hypertension in the Population of Mountain Shoriya Abstract  similar documents
T. A. Mulerova, S. A. Maksimov, M. Yu. Ogarkov, O. V. Gruzdeva, A. V. Ponasenko, V. N. Maksimov, M. I. Voyevoda, E. S. Filimonov, G. V. Artamonova
"... Aim. To study the combined effect of emcardiovascular/em risk factors and genetic markers that encode ..."
 
Vol 6, No 4 (2010) LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... The most socially significant emcardiovascular/em diseases are recently considered from the standpoint ..."
 
Vol 1, No 1 (2005) EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE Abstract  similar documents
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen
"... Expert consensus document on angiotensin converting enzyme inhibitors in emcardiovascular/em disease. ..."
 
Vol 15, No 4 (2019) The Study of the Fixed Dose Combination of Lisinopril with Prolonged Indopamide (FIXLINDA) with Daily Blood Pressure Monitoring and Diuresis in Hypertensive Patients Abstract  similar documents
M. P. Savenkov, S. N. Ivanov, M. P. Mikhaylusova, M. V. Borschevskaya, A. M. Savenkova, N. Y. Kozachenko, E. S. Sherifova
"... Аim. To study the efficacy, tolerability and safety of using a fixed dose combination of an emACE/em ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... ), hypertension (HT) and history of myocardial infarction (MI) in the frame of emCardiovascular/em Disease Registry ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... in hypertensive men with high emcardiovascular/em risk. Materials and methods. Hypertensive men (n=21) with high ..."
 
Vol 1, No 1 (2005) ASSESSMENT OF AWARENESS LEVEL OF OWN DISEASE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov, S. Y. Martsevich
"... Arterial hypertension (AH) is the most frequent risk factor of emcardiovascular/em diseases and related ..."
 
Vol 2, No 4 (2006) ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva
"... Aim. To estimate an effect of enalapril, angiotensin converting enzyme (emACE/em) inhibitor , on left ..."
 
Vol 4, No 5 (2008) EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS Abstract  similar documents
S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya
"... Aim. To study adjuvant effect of betahistine dihydrochloride to emACE/em inhibitors in patients ..."
 
Vol 6, No 1 (2010) EVOLUTION STAGES OF LOW RENIN HYPERTENSION Abstract  similar documents
S. V. Akhadov, G. R. Ruzbanova, G. S. Molchanovа
"... and the high emcardiovascular/em risk were included into the study. All patients received emACE/em inhibitor, enalapril ..."
 
Vol 9, No 2 (2013) ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES Abstract  similar documents
Z. M. Safiullina, S. V. Shalaev
"... fibrillation are presented. Effects of these drugs on emcardiovascular/em events in atrial fibrillation are analyzed ..."
 
Vol 8, No 1 (2012) BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE Abstract  similar documents
M. V. Leonova
"... channel blockers, emACE/em inhibitors) is evaluated. Special considerations of beta-blockers use ..."
 
Vol 15, No 2 (2019) A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist Abstract  similar documents
S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina
 
Vol 1, No 2 (2005) ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov
"... converting enzyme (emACE/em) inhibitor spirapril in patients with arterial hypertension (AH). Material ..."
 
Vol 14, No 6 (2018) Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) Abstract  PDF (Eng)  similar documents
L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
"... was maximal for emACE/em inhibitors/angiotensin receptor blockers (83.6%), dual antiplatelet therapy (79.9%) and β ..."
 
Vol 8, No 5 (2012) THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE Abstract  similar documents
S. Y. Marcevich, M. L. Ginzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. Y. Drozdova, E. V. Danijel's, A. V. Fokina
"... -blockers, 35.3% — emACE/em inhibitors, 15.7% — antiplatelet drugs, 1.9% — statins. Reduction in the hospital ..."
 
Vol 6, No 2 (2010) RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Influence of the combined antihypertensive therapy, including combination of emACE/em inhibitors ..."
 
Vol 6, No 4 (2010) COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE Abstract  similar documents
O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova
"... Aim. To evaluate influence of the combined therapy with emACE/em inhibitor (perindopril), diuretic ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... .05) increased. In 2014-2015 the frequency of the prescriptions of emACE/em inhibitors decreased (77.8 vs 86.5%; p0 ..."
 
Vol 3, No 3 (2007) STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? Abstract  similar documents
R. G. Oganov, G. V. Pogosova
"... Results of current studies devoted to relationship between stress and emcardiovascular/em morbidity ..."
 
Vol 13, No 1 (2017) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) Abstract  PDF (Eng)  similar documents
S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev
"... , concomitant emcardiovascular/em diseases (CVD) and noncardiac diseases were analyzed. We estimated accordance ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... patients received beta-blocker, nitrate, emACE/em inhibitors and acetylsalicylic acid. Frequency of lipid ..."
 
Vol 6, No 5 (2010) NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya
"... are presented. The advantages of emACE/em inhibitor+calcium channel blocker combination are shown in terms ..."
 
Vol 11, No 3 (2015) THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... pathogenic mechanisms of hypertension. The combination of an emACE/em inhibitor and a dihydropyridine calcium ..."
 
Vol 11, No 2 (2015) THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS Abstract  similar documents
E. EL. Trisvetova
"... and long-lasting action. Lercanidipine had shown both in monotherapy and in combination with emACE/em inhibitors ..."
 
Vol 5, No 6 (2009) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, L. A. Sokolova, V. V. Jakusevich, J. V. Lukina, M. A. Maximova, A. V. Zaharova, A. A. Serazhim, V. P. Voronina
"... with original amlodipine (Norvasc) in monotherapy and in combination with angiotensin converting enzyme (emACE/em ..."
 
Vol 2, No 1 (2006) THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY Abstract  similar documents
M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov
"... Aim. To assess an influence of emACE/em inhibitor enalapril on daily profile of blood pressure (BP ..."
 
Vol 6, No 4 (2010) HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE Abstract  similar documents
G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov
"... The correlation of age-dependent reduction in sex hormones level and changes of emcardiovascular/em ..."
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of emcardiovascular/em ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 5, No 2 (2009) EFFECT OF ANTIHYPERTENSIVE DRUGS ON QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
G. F. Andreeva, A. D. Deev, V. M. Gorbunov
"... not affect QoL. emACE/em inhibitors similarly improved QoL. Conclusion. Antihypertensive drugs (diltiazem ..."
 
Vol 2, No 1 (2006) DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT Abstract  similar documents
O. V. Andropova, V. N. Anokhin
 
Vol 1, No 1 (2005) MENOPAUSE AND CARDIOVASCULAR RISK Abstract  similar documents
D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva
"... A role of menopause as a emcardiovascular/em risk factor is reviewed. Menopause influence ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... Aim. To evaluate in a prospective 10-year follow-up study emcardiovascular/em mortality rate ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... complex compared to routine therapy in patients with diabetes type 2 and emACE/em inhibitor intolerance within ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... with emcardiovascular/em diseases are presented. The main practical ways to reduce the possible gastrointestinal ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the emcardiovascular/em diseases (CVD) and its prevention (odds ratio ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
"... emcardiovascular/em events incidence in patients with atherosclerosis, even if they have no arterial hypertension ..."
 
Vol 11, No 6 (2015) Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) Abstract  similar documents
O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko
"... Aim. To study the frequency and characteristics of alcohol use in outpatients with emcardiovascular/em ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... – arterial hypertension (HT) and hypercholesterolemia (HH) in patients with high risk of emcardiovascular/em ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... to provide high level of compliance in patients with emcardiovascular/em diseases. ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary prevention of emcardiovascular/em diseases is presented. Statins preventive ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... Data of the evidence based medicine about bisoprolol treatment of patients with emcardiovascular/em ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with emcardiovascular/em diseases is discussed ..."
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... modification of emcardiovascular/em complications in the perioperative period. Particular attention has recently ..."
 
Vol 1, No 3 (2005) RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... The emcardiovascular/em risk factors in patients with rheumatoid arthritis (RA) are reviewed ..."
 
1 - 100 of 528 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)